Excuse the formatting, here's a wee taste:

Oldenburg, Steven J., Ph.D. Silver Nanoparticles: Properties and Applications. Sigma-Aldrich.com, 2016.
Alexander, J. Wesley. History of the Medical Use of Silver*. Surgical Infections. Volume 10, Number 3 2009.
Regan, Fiona, James Chapman, and Timothy Sullivan. Nanoparticles in Anti-Microbial Materials: Use and Characterisation. Dublin: School of Chemical Sciences, 2012. p. 6.
The Return of Silver in Healing: Colloidal Silver - Nature's Alternative to Antibiotics. Healthline News. Educate-Yourself.org.
Fowler, Michael A., MBA. “Introduction” to “An Open Letter to the World About Colloidal Silver”. An Overview of Silver in Medical Mythology. 17 http://www.freegrab.net/silver%20overview%20fitzgerald.htm
18 Powell, Jim. Our Mightiest Germ Fighter. Science Digest, March 1978.
John Killen, Jr., M.D. Colloidal Silver. National Center for Complementary and Integrative Health, 2014. 19 https://nccih.nih.gov/health/silver
FDA Position on Colloidal Silver. EMR Labs, LLC. 2004. 20 https://www.quantumbalancing.com/news/cs_fda.htm
Corr, Peter and David Williams. The Pathway from Idea to Regulatory Approval: Examples for Drug Development. Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice; Lo B, Field MJ, editors. National Academy of Sciences, 2009. 22 http://www.ncbi.nlm.nih.gov/books/NBK22930/
The Facts on Silver: What is Silver?. Dartmouth Toxic Metals Superfund Research Program. 2010. 23 http://www.dartmouth.edu/~toxmetal/toxic-metals/more-metals/silver-faq.html
Silver: The Essentials. WebElements.com, 2016. 25 http://www.webelements.com/silver/
Corriher, Thomas. Making and Using Genuine Colloidal Silver. The Health Wyze Report & Fidelity Ministry, 2013. http://healthwyze.org/reports/633-making-and-using-genuine-colloidal-silver?showall=&start=1
Williams, Mike. Ions, not particles, make silver toxic to bacteria. Rice University News and Media, 2012. 27 http://news.rice.edu/2012/07/11/ions-not-particles-make-silver-toxic-to-bacteria-3/
Alan B. G. Lansdown, “A Pharmacological and Toxicological Profile of Silver as an Antimicrobial Agent in Medical Devices,” Advances in Pharmacological Sciences, vol. 2010, Article ID 910686, 16 pages, 2010. doi:10.1155/2010/91068628 http://www.hindawi.com/journals/aps/2010/910686/
Kuo-Hsiung Tseng, Heng-Lin Lee, Der-Chi Tien, Ya-Lan Tang, and Yi-Syuan Kao, “A Study of Antibioactivity of Nanosilver Colloid and Silver Ion Solution,” Advances in Materials Science and Engineering, vol. 2014, Article ID 371483, 6 pages, 2014. doi:10.1155/2014/37148329 http://www.hindawi.com/journals/amse/2014/371483/
Morones, Jose R., Jose L. Elechiguerra, Alejandra Camacho, Katherine Holt, Juan B. Kouri, Jose T. Ram´ırez, and Miguel J. Yacaman. "The Bactericidal Effect of Silver Nanoparticles." Journal of Nanotechnology(2005): 2346-353. Nanotechnology. IOP, 26 Aug. 2005. 30https://www.researchgate.net/profile/Alejandra_Camacho2/publication/46149380_The_Bactericidal_Effect_of_Silver_Nanoparticles/links/0a85e53098300516c5000000.pdf http://iopscience.iop.org/article/10.1088/0957-4484/16/10/059/meta
Owens, Brian. “Silver makes antibiotics thousands of times more effective”. Nature.com. 2013. 32 http://www.nature.com/news/silver-makes-antibiotics-thousands-of-times-more-effective-1.13232
Elechiguerra JL, Burt JL, Morones JR, et al. Interaction of silver nanoparticles with HIV-1. Journal of Nanobiotechnology. 2005;3:6. doi:10.1186/1477-3155-3-6.35 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1190212/
Mori, et al. Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale Research Letters 2013 8.93. 36 http://www.sciencedirect.com/science/article/pii/S0166093411003788
Xiang, Dongxi, Yang, Zheng, Duan, Wei, Li, Xiujing, Yin, Jianjian, Shigdar, Sarah, O'Connor, Michael Liam, Marappan, Manju, Zhao, Xiaojuan, Miao, Yingqiu, Xiang, Bin and Zheng, Conglong 2013, Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo, International Journal of Nanomedicine, vol. 8, no. 1, pp. 4103-4114. 37 http://dro.deakin.edu.au/view/DU:30059383
Lara HH, Ayala NV, Ixtepan-Turrent L, Rodriguez-Padilla C (2010) Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnol 8(1). Doi:10.1186/1477-3155-8-1
Rogers JV, Parkinson CV, Choi YW, Speshock JL, Hussain SM. A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation. Nanoscale ResLett 2008; 3: 129–133. 40 http://nanoscalereslett.springeropen.com/articles/10.1007/s11671-008-9128-2
Kim KJ, Sung WS, Moon SK, Choi JS, Kim JG, Lee DG. Antifungal effect of silver nanoparticles on dermatophytes. Journal of Microbiology and Biotechnology 2008;18:1482–4. 41 http://www.ncbi.nlm.nih.gov/pubmed/18756112
R. Manjumeena , D. Duraibabu , J. Sudha , P.T. Kalaichelvan. Biogenic nanosilver incorporated reverse osmosis membrane for antibacterial and antifungal activities against selected pathogenic strains: An enhanced eco-friendly water disinfection approach. Journal of Environmental Science and Health, Part A . Vol. 49, Iss. 10, 2014 42 http://www.tandfonline.com/doi/abs/10.1080/10934529.2014.897149